---
title: "SHENGLAN TECHNOLOGY: The company's liquid cooling plate products are currently only in the small batch trial production stage"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253123552.md"
description: "On August 15th, SHENGLAN TECHNOLOGY stated on the interactive platform that the liquid cooling plate products developed and produced by the company can be used in liquid-cooled servers, and are currently only in the small batch trial production stage"
datetime: "2025-08-15T00:57:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253123552.md)
  - [en](https://longbridge.com/en/news/253123552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253123552.md)
generator: "portal-rs"
---

# SHENGLAN TECHNOLOGY: The company's liquid cooling plate products are currently only in the small batch trial production stage

On August 15th, SHENGLAN TECHNOLOGY stated on the interactive platform that the liquid cooling plate products developed and produced by the company can be used in liquid cooling servers, and are currently only in the small batch trial production stage

### Related Stocks

- [300843.CN](https://longbridge.com/en/quote/300843.CN.md)

## Related News & Research

- [Mexico pushes back on US ruling on strawberry dumping](https://longbridge.com/en/news/296374650.md)
- [peaq: peaqOS integrates World ID for private human verification - 22 Aug 2026](https://longbridge.com/en/news/296680578.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**